Abstract:Background: Beyond the direct effect of COVID-19 infection on young people, the wider impact of the pandemic on otherinfectious diseases remains unknown. Objective: This study aims to assess changes in the incidence and mortality of 42 notifiable infectious diseases during thepandemic among children and adolescents in China, compared with prepandemic levels. Methods: The Notifiable Infectious Disease Surveillance System of China was used to detect new cases and fatalities amongindividuals aged 5-22 years across 42 notifiable infectious diseases spanning from 2018 to 2021. These infectious diseases werecategorized into 5 groups: respiratory, gastrointestinal and enterovirus, sexually transmitted and blood-borne, zoonotic, andvector-borne diseases. Each year (2018-2021) was segmented into 4 phases: phase 1 (January 1-22), phase 2 (January 23-April7), phase 3 (April 8-August 31), and phase 4 (September 1-December 31) according to the varying intensities of pandemicrestrictive measures in 2020. Generalized linear models were applied to assess the change in the incidence and mortality withineach disease category, using 2018 and 2019 as the reference. Results: A total of 4,898,260 incident cases and 3701 deaths were included. The overall incidence of notifiable infectiousdiseases decreased sharply during the first year of the COVID-19 pandemic (2020) compared with prepandemic levels (2018 and2019), and then rebounded in 2021, particularly in South China. Across the past 4 years, the number of deaths steadily decreased.The incidence of diseases rebounded differentially by the pandemic phase. For instance, although seasonal influenza dominatedrespiratory diseases in 2019, it showed a substantial decline during the pandemic (percent change in phase 2 2020: 0.21, 95% CI0.09-0.50), which persisted until 2021 (percent change in phase 4 2021: 1.02, 95% CI 0.74-1.41). The incidence of gastrointestinal and enterovirus diseases decreased by 33.6% during 2020 but rebounded by 56.9% in 2021, mainly driven by hand, foot, andmouth disease (percent change in phase 3 2021: 1.28, 95% CI 1.17-1.41) and infectious diarrhea (percent change in phase 3 2020:1.22, 95% CI 1.17-1.28). Sexually transmitted and blood-borne diseases were restrained during the first year of 2021 but reboundedquickly in 2021, mainly driven by syphilis (percent change in phase 3 2020: 1.31, 95% CI 1.23-1.40) and gonorrhea (percentchange in phase 3 2020: 1.10, 95% CI 1.05-1.16). Zoonotic diseases were not dampened by the pandemic but continued to increaseacross the study period, mainly due to brucellosis (percent change in phase 2 2020: 0.94, 95% CI 0.75-1.16). Vector-borne diseasesshowed a continuous decline during 2020, dominated by hemorrhagic fever (percent change in phase 2 2020: 0.68, 95% CI0.53-0.87), but rebounded in 2021.Conclusions: The COVID-19 pandemic was associated with a marked decline in notifiable infectious diseases in Chinesechildren and adolescents. These effects were not sustained, with evidence of a rebound to prepandemic levels by late 2021. Toeffectively address the postpandemic resurgence of infectious diseases in children and adolescents, it will be essential to maintaindisease surveillance and strengthen the implementation of various initiatives. These include extending immunization programs,prioritizing the management of sexually transmitted infections, continuing feasible nonpharmaceutical intervention projects, andeffectively managing imported infections

Paradoxical deterioration during the course of antituberculous treatment.

Impact of the COVID-19 pandemic on infectious disease hospitalizations of neonates at a tertiary academic hospital: a cross-sectional study

Temporal shifts in 24 notifiable infectious diseases in China before and during the COVID-19 pandemic

Changes in Incidence of Notifiable Infectious Diseases in China Under the Prevention and Control Measures of COVID-19

Co-benefits of nonpharmaceutical intervention against COVID-19 on infectious diseases in China: A large population-based observational study

Carbon-13 8nuclear magnetic resonance spectroscopy of naturally occurring substances. XXXIII. The ochrolifuanines and emetine.

The indirect impacts of nonpharmacological COVID-19 control measures on other infectious diseases in Yinchuan, Northwest China: a time series study

Persistence and Variation of the Indirect Effects of COVID-19Restrictions on the Spectrum of Notifiable Infectious Diseases Inchina:Analysis of National Surveillance among Children Andadolescents from 2018 to 202

[Pathology of the placenta. VIII. Asphyxial infiltrates of the placenta].

Nursing documentation in clinical practice : Instrument development and evaluation of a comprehensive intervention programme

The Impact of COVID-19 Pandemic on Reported Notifiable Infectious Diseases in China: an Interrupted Time Series Analysis

Immunity Debt Regarding the Aspect of Influenza in the Post-COVID-19 Era in Taiwan

Comparison of 19 major infectious diseases during COVID-19 epidemic and previous years in Zhejiang, implications for prevention measures

Rising incidence of gonorrhea in Taiwan amid the COVID-19 pandemic: a nationwide surveillance study

Changing epidemic patterns of infectious diseases during and after COVID-19 pandemic in Taiwan

Impact of the COVID-19 pandemic on infectious diseases reporting

Women who develop breast cancer

Impact of non-pharmaceutical interventions on the incidences of vaccine-preventable diseases during the COVID-19 pandemic in the eastern of China

Effects of COVID-19 Prevention Measures on Other Common Infections, Taiwan

Impact of COVID-19 Pandemic on Pre-Treatment Delays, Detection, and Clinical Characteristics of Tuberculosis Patients in Ningxia Hui Autonomous Region, China

The Impact of COVID-19 Lockdown on Cases of and Deaths from AIDS, Gonorrhea, Syphilis, Hepatitis B, and Hepatitis C: Interrupted Time Series Analysis.